The DSRU is at ICPE in Philadelphia!

The DSRU team is attending the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia.

Come and meet our team at booth 204, where you can find out about our hospital PASS studies, our CPRD studies and DSRU Consulting.

Find out about our research from our posters:

Monday 26th August
Characterisation of Drug Interaction Related Signals Leading to EU Regulatory Action and a Methodological Review of Novel Drug Interaction Signal Detection Methods in the Post-Marketing Setting
D Roy, L Hazell, V Osborne, S Shakir

Impact Analyses of European Pharmacovigilance Interventions on Public Health Burden
S Lane, E Lynn, J Slattery, S Shakir

Wednesday 28th August
Monitoring the Safety of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results from a PASS
S Dhanda, V Osborne, D Roy, S Shakir

Utilisation of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results from a PASS
S Dhanda, V Osborne, D Roy, S Shakir

Utilisation Of Dulaglutide In Primary Care In England: Interim Results from a Post Authorisation Safety Study
M Davies, L Hazell, S Dhanda, V Osborne, A K Ali, S Shakir

The Association between Direct Oral Anticoagulants and Gynaecological Bleeding in Women v. Standard Therapy: A Systematic Review
S Dhanda, V Osborne, S Shakir

Risk Factors of Major Bleeding in Patients Prescribed Rivaroxaban in Primary Care in England
D Roy, S Dhanda, L Wise, S Shakir